SEVERE HEMOPHILIA B

Clinical trials for SEVERE HEMOPHILIA B explained in plain language.

Never miss a new study

Get alerted when new SEVERE HEMOPHILIA B trials appear

Sign up with your email to follow new studies for SEVERE HEMOPHILIA B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New hemophilia shot shows early promise in small safety trial

Disease control Completed

This early-phase study tested a new drug called MG1113, given as a shot under the skin, in 15 adults with severe hemophilia A or B. The main goal was to check safety and how the drug moves through the body. Participants received multiple doses to see if the drug is well-tolerated…

Matched conditions: SEVERE HEMOPHILIA B

Phase: PHASE1 • Sponsor: GC Biopharma Corp • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC

SEVERE HEMOPHILIA B

Get alerted when new SEVERE HEMOPHILIA B trials appear

New hemophilia shot shows early promise in small safety trial